UC San Francisco received the most funding from the National Institutes of Health (NIH) of any public university in 2023, driving one of the most diverse portfolios of scientific research in the nation.
Millions of internal documents to be released as condition of North Carolina’s $47.8 million settlement with electronic cigarette maker Juul Labs.
A genetic mutation that makes cancer cells hardy can be engineered into T cells, giving them superhuman strength.
The latest in a continuous series of portraits and quotes from UCSF Cancer Services staff and faculty, the See Us Portrait Project highlights underrepresented minority faculty and staff who are dedicated leaders in diversity, equity, and inclusion at the Cancer Center.
This is a newly created role charged with developing and helping implement strategies to enhance and optimize clinical operations in the adult cancer service line, with a particular focus on surgical oncology.
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025. A long-time ASCO member and volunteer, Small will take office as president-elect immediately following the ASCO Annual Business Meeting in Chicago on June 3, 2024.
A recent $1 million gift has helped establish the UCSF Sarcoma Cellular Therapy Initiative led by Kole Roybal, PhD, director of the UCSF Parker Institute for Cancer Immunotherapy, and Brian Schulte, MD, medical director of the UCSF Sarcoma Program.